Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry

Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

September 20, 2018

May 15, 2020

Center for Drug Evaluation and Research

610cbeb8-d9d2-45ae-8410-67587f5666eb

Related Documents

Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs: Guidance for Industry

Guidance DocumentDecember 7, 2023Center for Drug Evaluation and Research
View Details →

Definitions of Suspect Product and Illegitimate Product for Verification Obligations Under the Drug Supply Chain Security Act Guidance for Industry: Guidance for Industry

Guidance DocumentMarch 16, 2023Center for Drug Evaluation and Research
View Details →

Grandfathering Policy for Packages and Homogenous Cases of Product Without a Product Identifier

Guidance DocumentSeptember 19, 2018Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.